Evidence map›Paper›PMID 39285940›Full record

ArticleFrontiers in cellular neuroscience2024

Schwann cell-derived exosomes ameliorate peripheral neuropathy induced by ablation of dicer in Schwann cells.

Lei Wang, XueRong Lu, Alexandra Szalad, Xian Shuang Liu, Yi Zhang, Xinli Wang, William Anthony Golembieski, Brianna Powell, Mikkala Mccann, Mei Lu and 2 more

Abstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lei WangDepartment of Neurology, Henry Ford Hospital, Detroit, MI, United States.
XueRong LuDepartment of Neurology, Henry Ford Hospital, Detroit, MI, United States.
Alexandra SzaladDepartment of Neurology, Henry Ford Hospital, Detroit, MI, United States.
Xian Shuang LiuDepartment of Neurology, Henry Ford Hospital, Detroit, MI, United States.
Yi ZhangDepartment of Neurology, Henry Ford Hospital, Detroit, MI, United States.
Xinli WangDepartment of Neurology, Henry Ford Hospital, Detroit, MI, United States.
William Anthony GolembieskiDepartment of Neurology, Henry Ford Hospital, Detroit, MI, United States.
Brianna PowellDepartment of Neurology, Henry Ford Hospital, Detroit, MI, United States.
Mikkala MccannDepartment of Neurology, Henry Ford Hospital, Detroit, MI, United States.
Mei LuDepartment of Biostatistics and Research Epidemiology, Henry Ford Hospital, Detroit, MI, United States.
Michael ChoppDepartment of Neurology, Henry Ford Hospital, Detroit, MI, United States.
Zheng Gang ZhangDepartment of Neurology, Henry Ford Hospital, Detroit, MI, United States.

Funding

Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic miceR01DK124377 · NIDDK · HENRY FORD HEALTH SYSTEM · PI WANG, LEI · 2020 to 2023
$1.6M
Investigating the role of gut extracellular vesicles in diabetic peripheral neuropathyR01DK135970 · NIDDK · HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES · PI Xianshuang Liu · 2024 to 2026
$1.6M
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic miceR56DK115601 · NIDDK · HENRY FORD HEALTH SYSTEM · PI WANG, LEI · 2018 to 2018
$376k
NIDDK NIH HHS R01 DK124377NIDDK NIH HHS R01 DK135970NIDDK NIH HHS R56 DK115601
6 · The paper itself

Abstract

Background: MicroRNAs (miRNAs) in Schwann cells (SCs) mediate peripheral nerve function. Ablating Dicer, a key gene in miRNA biogenesis, in SCs causes peripheral neuropathy. Exosomes from healthy SCs (SC-Exo) ameliorate diabetic peripheral neuropathy in part via miRNAs. Thus, using transgenic mice with conditional and inducible ablation of Dicer in proteolipid protein (PLP) expressing SCs (PLP-cKO), we examined whether SC-Exo could reduce peripheral neuropathy in PLP-cKO mice. Methods: PLP-cKO mice at the age of 16 weeks (8 week post-Tamoxifen) were randomly treated with SC-Exo or saline weekly for 8 weeks. Age-and sex-matched wild-type (WT) littermates were used as controls. Peripheral neurological functions, sciatic nerve integrity, and myelination were analyzed. Quantitative RT-PCR and Western blot analyses were performed to examine miRNA and protein expression in sciatic nerve tissues, respectively. Results: Compared to the WT mice, PLP-cKO mice exhibited a significant decrease in motor and sensory conduction velocities, thermal sensitivity, and motor coordination. PLP-cKO mice exhibited substantial demyelination and axonal damage of the sciatic nerve. Treatment of PLP-cKO mice with SC-Exo significantly ameliorated the peripheral neuropathy and sciatic nerve damage. PLP-cKO mice showed a substantial reduction in a set of Dicer-related miRNAs known to regulate myelination, axonal integrity, and inflammation such as miR-138, -146a and - 338 in the sciatic nerve. In addition, PLP-cKO mice exhibited significant reduction of myelin forming proteins, early growth response 2 (EGR2) and sex determining region Y-box10 (Sox10), but significantly increased myelination inhibitors, Notch1, c-Jun, and Sox2 and the axonal growth inhibitor phosphatase and tens in homolog (PTEN). However, SC-Exo treatment reversed the PLP-cKO altered miRNAs and proteins. Conclusion: This study demonstrates that exogenous SC-Exo ameliorate peripheral neuropathy induced by Dicer ablation in PLP expressing SCs. The therapeutic benefit may be mediated by the SC-Exo altered miRNAs and their targeted genes.

Indexed as

dicerexosomesmicemicroRNAsperipheral neuropathySchwann cells

Identifiers

PMID39285940
PMCPMC11402728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.